DaVita Clinical Research, a specialty contract research organization with services spanning the full spectrum of drug and device development, today announced that company representatives and...
DaVita Inc. (NYSE: DVA), a leading independent medical group and a leading provider of kidney care services in the United States, joins the fight against diabetes during National Diabetes Month by...
DaVita Inc. (NYSE: DVA) today announced results for the quarter ended September 30, 2016. Net income attributable to DaVita Inc. for the three months ended September 30, 2016 was $571 million, or...
DaVita Kidney Care ("DaVita"), a division of DaVita Inc. (NYSE: DVA), a leading provider in kidney care services, today announced information concerning its patients enrolled in plans governed by...
DaVita Inc. (NYSE: DVA), a leading independent medical group and a leading provider of kidney care services in the United States, today announced the total in donations raised during Tour DaVita,...